ReviewFrontiers in immunology2021

The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses.

Amber Papillion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.